Dietrich Alexander Ruess (Dietrich A Ruess, D A Ruess)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Transcription Factor

Clinical Practice

Top Venues

Journal of magnetic resonance imaging : JMRI

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wilfried Reichardt, Tabea Gewalt, Philipp Hafner, Steffen J Keller, Xun Chen, Asma Alrawashdeh, Yayu Li, Solène Besson, Stefan Fichtner-Feigl, Dominik von Elverfeldt, Huda Jumaa, Dietrich Alexander Ruess
19 Fluorine-MRI Based Longitudinal Immuno-Microenvironment-Monitoring for Pancreatic Cancer. Journal of magnetic resonance imaging : JMRI (2024)
Julian Hipp, L Rist, Sophia Chikhladze, Dietrich Alexander Ruess, Stefan Fichtner-Feigl, U A Wittel
Perioperative risk of pancreatic head resection-nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice. Langenbeck's archives of surgery 407 (5) (2022)
Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, Michael Quante, Heiko Becker
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers 14 (23) (2022)
Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, Michael Quante, Heiko Becker
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers 14 (23) (2022)
Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, Michael Quante, Heiko Becker
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers 14 (23) (2022)
Friederike Inga Nollmann, Dietrich Alexander Ruess
Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising? Biomedicines 8 (8) (2020)
Derya Bakırdöğen, Dietrich Alexander Ruess, Jiaoyu Ai, Hana Algül
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB. Cancers 11 (7) (2019)
Dietrich Alexander Ruess, Guus J Heynen, Katrin J Ciecielski, Jiaoyu Ai, Alexandra Berninger, Derya Kabacaoglu, Kıvanç Görgülü, Zahra Dantes, Sonja M Wörmann, Kalliope N Diakopoulos, Angeliki F Karpathaki, Marlena Kowalska, Ezgi Kaya-Aksoy, Liang Song, Eveline A Zeeuw van der Laan, María P López-Alberca, Marc Nazaré, Maximilian Reichert, Dieter Saur, Mert M Erkan, Ulrich T Hopt, Bruno Sainz, Walter Birchmeier, Roland M Schmid, Marina Lesina, Hana Algül
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nature medicine 24 (7) (2018)